Xiaodi Gong

455 total citations
19 papers, 326 citations indexed

About

Xiaodi Gong is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Xiaodi Gong has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Biomaterials. Recurrent topics in Xiaodi Gong's work include Endometrial and Cervical Cancer Treatments (3 papers), FOXO transcription factor regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaodi Gong is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), FOXO transcription factor regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xiaodi Gong collaborates with scholars based in China, Taiwan and Hong Kong. Xiaodi Gong's co-authors include Jiongyi Wang, Wenying Zhang, Feng Liu, Feifei Kong, Bin Jiang, Haihua Yuan, Mei Zhao, Bin Jiang, Xiao Sun and Linlin Yang and has published in prestigious journals such as Journal of Controlled Release, Small and Materials & Design.

In The Last Decade

Xiaodi Gong

17 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodi Gong China 10 144 60 57 49 47 19 326
Yingui Sun China 10 153 1.1× 34 0.6× 21 0.4× 30 0.6× 33 0.7× 17 361
Shilpa Patil India 10 91 0.6× 48 0.8× 47 0.8× 24 0.5× 58 1.2× 17 304
Chien-Yi Ho Taiwan 10 137 1.0× 34 0.6× 41 0.7× 53 1.1× 35 0.7× 10 337
Fangli Cao China 12 109 0.8× 110 1.8× 26 0.5× 85 1.7× 104 2.2× 25 378
Dimitrios Giakoumettis Greece 10 81 0.6× 25 0.4× 34 0.6× 30 0.6× 34 0.7× 30 296
Murad Alahdal China 14 314 2.2× 97 1.6× 199 3.5× 53 1.1× 49 1.0× 32 627
Dang Tien Truong Vietnam 6 137 1.0× 62 1.0× 38 0.7× 24 0.5× 62 1.3× 13 358
Daniel Böhmer Slovakia 12 137 1.0× 67 1.1× 46 0.8× 27 0.6× 87 1.9× 46 440

Countries citing papers authored by Xiaodi Gong

Since Specialization
Citations

This map shows the geographic impact of Xiaodi Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodi Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodi Gong more than expected).

Fields of papers citing papers by Xiaodi Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodi Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodi Gong. The network helps show where Xiaodi Gong may publish in the future.

Co-authorship network of co-authors of Xiaodi Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodi Gong. A scholar is included among the top collaborators of Xiaodi Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodi Gong. Xiaodi Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gao, Yifan, Xiaodi Gong, Fan Du, et al.. (2025). Regulated PEGylation of cationic nanogels for enhanced siRNA delivery and orthotopic ovarian tumor therapy. Journal of Controlled Release. 386. 114128–114128. 1 indexed citations
2.
Sun, Hao, et al.. (2024). Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer. Infectious Agents and Cancer. 19(1). 13–13. 15 indexed citations
3.
Gong, Xiaodi, et al.. (2024). Pyroptosis-associated genes and tumor immune response in endometrial cancer. Discover Oncology. 15(1). 433–433.
4.
5.
Gong, Xiaodi, Jing Wang, Linlin Yang, et al.. (2023). Enhanced Chemodynamic Therapy Mediated by a Tumor‐Specific Catalyst in Synergy with Mitophagy Inhibition Improves the Efficacy for Endometrial Cancer. Small. 19(33). e2301497–e2301497. 20 indexed citations
6.
Yang, Linlin, Xiaodi Gong, Jing Wang, et al.. (2022). Functional mechanisms of TRPS1 in disease progression and its potential role in personalized medicine. Pathology - Research and Practice. 237. 154022–154022. 12 indexed citations
7.
Gong, Xiaodi & Xiaojun Liu. (2022). In-depth analysis of the expression and functions of signal transducers and activators of transcription in human ovarian cancer. Frontiers in Oncology. 12. 1054647–1054647. 4 indexed citations
8.
Li, Lijuan, Yunxia Cui, Yang Chen, et al.. (2022). Novel chlorpromazine derivatives as anti-endometrial carcinoma agents with reduced extrapyramidal side effects. Bioorganic Chemistry. 127. 106008–106008. 8 indexed citations
9.
Yang, Linlin, Jing Wang, Xiaodi Gong, et al.. (2022). Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis. Frontiers in Genetics. 12. 728827–728827. 11 indexed citations
10.
Wang, Zhongtang, et al.. (2022). Improving Yield and Quality of Jujube by Dynamic Application of Nitrogen. Journal of Plant Growth Regulation. 42(6). 3459–3470. 2 indexed citations
11.
Gong, Xiaodi, Xin Pu, Jing Wang, et al.. (2021). Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy. International Journal of Nanomedicine. Volume 16. 6661–6679. 25 indexed citations
12.
Cui, Yunxia, Huiwen Wu, Linlin Yang, et al.. (2021). Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB. Frontiers in Oncology. 11. 665832–665832. 21 indexed citations
13.
Xu, Yawen, Yaqiang Li, Xiaodi Gong, et al.. (2019). Nanofibrous Wharton's jelly scaffold in combination with adipose-derived stem cells for cartilage engineering. Materials & Design. 186. 108216–108216. 46 indexed citations
14.
Zhang, Wenying, Xiaodi Gong, Qiongwei Wu, et al.. (2018). The Clearance of High-Risk Human Papillomavirus is Sooner After Thin Loop Electrosurgical Excision Procedure (t-LEEP). Journal of Investigative Surgery. 32(6). 560–565. 6 indexed citations
15.
Zhu, Xiaorong, Xiaodi Gong, & Danny H. K. Tsang. (2017). The optimal macro control strategies of service providers and micro service selection of users: quantification model based on synergetics. Wireless Networks. 24(6). 1991–2004. 3 indexed citations
16.
Kong, Feifei, Zengqiang Qu, Haihua Yuan, et al.. (2014). Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncology Reports. 31(6). 2660–2668. 75 indexed citations
17.
Kong, Feifei, Haihua Yuan, Jiongyi Wang, et al.. (2014). FOXM1 Regulated by ERK Pathway MediatesTGF-1-Induced EMT in NSCLC. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(1). 29–37. 27 indexed citations
18.
Gong, Xiaodi, et al.. (2013). Gene Polymorphisms of OPRM1 A118G and ABCB1 C3435T May Influence Opioid Requirements in Chinese Patients with Cancer Pain. Asian Pacific Journal of Cancer Prevention. 14(5). 2937–2943. 49 indexed citations
19.
Gong, Xiaodi, et al.. (2013). [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].. PubMed. 35(8). 572–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026